Literature DB >> 7811041

Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue culture.

R A Heijtink1, J Kruining, G A de Wilde, J Balzarini, E de Clercq, S W Schalm.   

Abstract

The inhibitory effects of the 9-(2-phosphonylmethoxyethyl)adenine-related compounds (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)-adenine, (S)-9-(3-fluoro-2-phosphonylmethoxypropyl)adenine, (R)-9-(2-phosphonylmethoxypropyl)adenine, (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine, and (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine on human hepatitis B virus replication in the human hepatoma cell line HepG2 2.2.15 and duck hepatitis B virus infection in primary duck hepatocytes were investigated. (R)-9-(2-phosphonylmethoxypropyl-2,6-diaminopurine had the lowest 50% inhibitory concentrations against hepatitis B virus and duck hepatitis B virus, 0.22 and 0.06 microM, respectively, i.e., two- to fivefold lower concentrations than required for (R)-9-(2-phosphonylmethoxypropyl)adenine and 9-(2-phosphonylmethoxyethyl)adenine. All compounds were not toxic in vitro at a concentration of 100 microM.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811041      PMCID: PMC284706          DOI: 10.1128/AAC.38.9.2180

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  A cell culture assay for compounds which inhibit hepatitis B virus replication.

Authors:  B E Korba; G Milman
Journal:  Antiviral Res       Date:  1991 Mar-Apr       Impact factor: 5.970

Review 2.  Broad-spectrum anti-DNA virus and anti-retrovirus activity of phosphonylmethoxyalkylpurines and -pyrimidines.

Authors:  E De Clercq
Journal:  Biochem Pharmacol       Date:  1991-08-08       Impact factor: 5.858

3.  Detection of integration during active replication of hepatitis B virus in the liver.

Authors:  P J Boender; S W Schalm; R A Heijtink
Journal:  J Med Virol       Date:  1985-05       Impact factor: 2.327

4.  Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

Authors:  M A Sells; M L Chen; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

5.  Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro.

Authors:  T Yokota; K Konno; E Chonan; S Mochizuki; K Kojima; S Shigeta; E de Clercq
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

6.  Inhibitory effects of selected antiviral compounds on human hepatitis B virus DNA synthesis.

Authors:  T Yokota; S Mochizuki; K Konno; S Mori; S Shigeta; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

7.  Immuno disc assay for screening duck hepatitis B surface antigen in serum, liver tissue and cultured hepatocytes.

Authors:  G A de Wilde; R A Heijtink
Journal:  J Virol Methods       Date:  1993-06       Impact factor: 2.014

8.  Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection.

Authors:  R A Heijtink; G A De Wilde; J Kruining; L Berk; J Balzarini; E De Clercq; A Holy; S W Schalm
Journal:  Antiviral Res       Date:  1993-06       Impact factor: 5.970

9.  Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine.

Authors:  J Balzarini; A Holy; J Jindrich; L Naesens; R Snoeck; D Schols; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

Review 10.  Therapeutic potential of phosphonylmethoxyalkylpurines and -pyrimidines as antiviral agents.

Authors:  E De Clercq
Journal:  Drugs Exp Clin Res       Date:  1990
  10 in total
  29 in total

1.  In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir.

Authors:  D Colledge; G Civitico; S Locarnini; T Shaw
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Cryopreservation enables long-term storage of 9-(2-phosphonylmethoxyethyl)adenine prodrug-loaded reconstituted lactosylated high-density lipoprotein.

Authors:  R L de Vrueh; T J van Berkel; M K Bijsterbosch
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

3.  Metabolic activation of pradefovir by CYP3A4 and its potential as an inhibitor or inducer.

Authors:  Chin-chung Lin; Che Fang; Salete Benetton; Gui-fen Xu; Li-Tain Yeh
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

4.  Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus.

Authors:  William E Delaney; Adrian S Ray; Huiling Yang; Xiaoping Qi; Shelly Xiong; Yuao Zhu; Michael D Miller
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

5.  Single-dose pharmacokinetics and metabolism of [14C]remofovir in rats and cynomolgus monkeys.

Authors:  Chin-Chung Lin; Christine Xu; Nanqun Zhu; David Lourenco; Li-Tain Yeh
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

6.  Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro.

Authors:  Julien Delmas; Olivier Schorr; Catherine Jamard; Craig Gibbs; Christian Trépo; Olivier Hantz; Fabien Zoulim
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

7.  Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B.

Authors:  Bulent Baran; Ozlem Mutluay Soyer; Asli Cifcibasi Ormeci; Suut Gokturk; Sami Evirgen; Hamza Ugur Bozbey; Filiz Akyuz; Cetin Karaca; Kadir Demir; Fatih Besisik; Derya Onel; Mine Gulluoglu; Selim Badur; Sabahattin Kaymakoglu
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

Review 8.  Alpha-carboxynucleoside phosphonates: direct-acting inhibitors of viral DNA polymerases.

Authors:  Jan Balzarini; Alan Ford; Nuala M Maguire; Jubi John; Kalyan Das; Eddy Arnold; Wim Dehaen; Anita Maguire
Journal:  Future Med Chem       Date:  2019-01-16       Impact factor: 3.808

9.  Inhibition of duck hepatitis B virus replication by 9-(2-phosphonylmethoxyethyl)adenine, an acyclic phosphonate nucleoside analogue.

Authors:  A J Nicoll; D L Colledge; J J Toole; P W Angus; R A Smallwood; S A Locarnini
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

10.  Alkoxyalkyl esters of 9-(s)-(3-hydroxy-2-phosphonomethoxypropyl) adenine are potent and selective inhibitors of hepatitis B virus (HBV) replication in vitro and in HBV transgenic mice in vivo.

Authors:  John D Morrey; Brent E Korba; James R Beadle; David L Wyles; Karl Y Hostetler
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.